Kola Blerina, Grossman Ashley B, Korbonits Márta
Department of Endocrinology, Barts and the London, Queen Mary's School of Medicine and Dentistry, University of London, London, UK.
Front Horm Res. 2008;36:198-211. doi: 10.1159/000115366.
AMP-activated protein kinase (AMPK) is a major regulator of energy metabolism at both the cell and at the whole body level. Numerous genetic and obesity models as well as human studies have suggested a role for AMPK in the physiological regulation of fatty acid and glucose metabolism, and in the regulation of appetite. Changes in AMPK activity have been reported in obesity, type 2 diabetes, the metabolic syndrome and cardiovascular disease, which jointly represent a major health and economical problem worldwide. Whether AMPK changes are one of the causes or the consequence of these pathological conditions remains a matter of debate, but AMPK clearly represents a major potential pharmacological target in the treatment of these conditions.
AMP激活的蛋白激酶(AMPK)是细胞和全身水平能量代谢的主要调节因子。众多遗传和肥胖模型以及人体研究表明,AMPK在脂肪酸和葡萄糖代谢的生理调节以及食欲调节中发挥作用。肥胖、2型糖尿病、代谢综合征和心血管疾病中均有AMPK活性变化的报道,这些疾病共同构成了全球主要的健康和经济问题。AMPK的变化是这些病理状况的原因之一还是结果仍存在争议,但AMPK显然是治疗这些疾病的主要潜在药理学靶点。